SOFTWAY MEDICAL acquired by FIVE ARROWS
Context
Securing a specialized digital health platform that generates in annual turnover, Five Arrows Principal Investments executed the buyout of Softway Medical in December 2019. This transaction officially transfers ownership from the target's former institutional backer, the private equity firm Naxicap Partners. Structured as a secondary leveraged buyout, the definitive agreement aligns with the acquiring sponsor's mandate to invest in mature technology assets. The strategic rationale articulated around the deal focuses on capitalizing on the accelerating digitization of medical infrastructure, a sub-sector attracting sustained investor interest due to strict regulatory compliance and the demand for workflow automation. By backing the software provider, the financial sponsor instantly captures a dominant market position within the French healthcare ecosystem. Throughout the transaction process, the buy-side execution was managed by Arma Partners, which acted as the exclusive financial advisor to the acquiring private equity fund.
-> Deep-dive in TMT (Tech, Media, Telecom) market trends
Target
Founded in 1999, Softway Medical specializes in cloud-native healthcare software solutions and designs comprehensive digital infrastructures aimed at optimizing clinical and administrative workflows across various European healthcare facilities. Located in Fuveau, within the Bouches-du-Rhône department, the technology provider maintains a massive operational footprint anchored by a deployment across 1,300 hospitals and clinics. This extensive penetration translates to a commanding 40 percent market share in its domestic institutional segment. Furthermore, the proprietary software ecosystem serves an established network comprising 1,300 specialized radiology centers, 700 multidisciplinary health centers, and 400 medical laboratories. To sustain the continuous development of its technological portfolio, the organization relies on a workforce exceeding 1,200 dedicated professionals. Under the operational leadership of Chief Executive Officer Guillaume Pascal, the software publisher executes a structured expansion strategy, notably conceptualized through its internal eNov development plan. This growth trajectory is historically supported by a vigorous external integration roadmap, characterized by the successful assimilation of ten strategic acquisitions, including the Belgian entity SBIM and epidemiology data firm EpiConcept. The enterprise also maintains active distribution channels in Canada. The core engineering focus remains firmly centered on translating complex healthcare data into actionable, secure digital environments.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Other operations with SOFTWAY MEDICAL
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 05/2025 | BAIN CAPITAL | SOFTWAY MEDICAL | FRANCE | Healthcare |
REFERENCES
Valuation range: EV 100M - 350M EUR
Revenue range: 50M - 100M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SOFTWAY MEDICAL by FIVE ARROWS are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: softway medical
Acquirer: five arrows